The Microbiome Business & Science Briefing
MicrobimeTimes
Reporting on The Latest Microbiome Business & Scientific Developments
TRENDING
MaaT Pharma Provides Update on MaaT013 (Xervyteg®) Potential Development Plan Following CHMP Negative Opinion After Re-examination• Evvy Raises $40M Series B to Scale AI-Powered Precision Diagnostics & Care Platform for Women’s Health• Armata Pharmaceuticals Receives U.S. FDA Breakthrough Therapy Designation for AP-SA02• GutAlive®: Microbiota Collection and Transport in Anaerobic Conditions• From Discovery to Disease Prevention: How the Biose–Siolta Partnership is Advancing a New Generation of Live Biotherapeutics• A pioneering gut bacterium passes Europe’s food-safety review under the EU Novel Food Regulation•

Month: April 2018

Belgian Microbiome Start-up A-Mansia Announces €13m First Close of Series A Financing
Finance

Belgian Microbiome Start-up A-Mansia Announces €13m First Close of Series A Financing

APR 28, 2018
Dutch Biotech Micreos ‘Alternative to Antibiotics’ Wins Ideas From Europe Finals
Infectious Disease & AMR

Dutch Biotech Micreos ‘Alternative to Antibiotics’ Wins Ideas From Europe Finals

APR 26, 2018
The Global Prebiotic Association Welcomes Founding, Board and Associate Members
Pharma & Human Health

The Global Prebiotic Association Welcomes Founding, Board and Associate Members

APR 26, 2018
New initiative in the fight against antibiotic resistance
Infectious Disease & AMR

New initiative in the fight against antibiotic resistance

APR 26, 2018
BioGaia AB – Interim management statement 1 January – 31 March 2018
Finance

BioGaia AB – Interim management statement 1 January – 31 March 2018

APR 25, 2018
Drinking Affects Mouth Bacteria Linked to Diseases
Pharma & Human Health

Drinking Affects Mouth Bacteria Linked to Diseases

APR 24, 2018
Synthetic Biologics Provides Update on Development of SYN-004 (ribaxamase), for the Prevention of C. difficile Infection
Infectious Disease & AMR

Synthetic Biologics Provides Update on Development of SYN-004 (ribaxamase), for the Prevention of C. difficile Infection

APR 23, 2018
AOBiome Therapeutics Expands Clinical-Stage Pipeline, Initiates Phase 2 Clinical Trial for Episodic Migraine
Clinical & Manufacturing

AOBiome Therapeutics Expands Clinical-Stage Pipeline, Initiates Phase 2 Clinical Trial for Episodic Migraine

APR 23, 2018
Prota Therapeutics Partners With World Leading Bioscience Company, Chr. Hansen
Oncology

Prota Therapeutics Partners With World Leading Bioscience Company, Chr. Hansen

APR 20, 2018
MIT Spinout, ReviveMed, Raises $1.5M to Advance its AI-Driven Metabolomic Platform for Drug Discovery
Finance

MIT Spinout, ReviveMed, Raises $1.5M to Advance its AI-Driven Metabolomic Platform for Drug Discovery

APR 20, 2018
Inocucor $15.9M Final Close of Series B Financing Brings Series B Total to $54.4M
Finance

Inocucor $15.9M Final Close of Series B Financing Brings Series B Total to $54.4M

APR 19, 2018